Eversept Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Eversept Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-272,900	Closed	-$2.49M	–	78
2022 Q4	$2.49M	Hold	272,900	–	–	0.22%	48
2022 Q3	$2.2M	Buy	272,900 +180,000	+194%	+$1.59M	0.19%	47
2022 Q2	$699K	Hold	92,900	–	–	0.05%	71
2022 Q1	$872K	Sell	92,900 -869,500	-90%	-$7.26M	0.07%	69
2021 Q4	$7.71M	Hold	962,400	–	–	0.49%	52
2021 Q3	$9.37M	Buy	962,400 +769,500	+399%	+$7.21M	0.65%	41
2021 Q2	$1.91M	Buy	+192,900	New	+$2.04M	0.13%	70

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Eversept Partners's TEVA Position: Q1 2026 in Review

Eversept Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2026, closing a stake of 660,177 shares — an estimated $20.6M sold.

Eversept Partners first reported a position in TEVA in Q3 2020 and held it in 22 quarters. The position peaked at $85M in Q1 2024. 653 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Eversept Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2026 after selling out during the quarter.
Eversept Partners sold 660,177 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $20.6M.
Eversept Partners first reported a position in Teva Pharmaceutical Industries Limited in Q3 2020 and held it in 22 quarters.
Eversept Partners's Teva Pharmaceutical Industries Limited position peaked at $85M in Q1 2024.
653 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.